Fintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Outperform recommendation. As of March 4, 2025, the average one-year ...
Hosted on MSN1mon
Evercore Inc. (NYSE:EVR) Q4 2024 Earnings Call TranscriptOur discussion of our results today is complementary to the press release, which is available on our website at evercore.com. This conference call is being webcast live in the For Investors ...
Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6, citing discounted valuation, a potential industry turnaround ...
Our discussion of our results today is complementary to the press release, which is available on our website at evercore.com. This conference call is being webcast live in the For Investors ...
It has been about a month since the last earnings report for Evercore (EVR). Shares have lost about 26.3% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
CEO John Weinberg highlighted that 2024 was Evercore's second-best year for revenue, reaching over $3 billion in adjusted net revenues, with strength across all business segments. He noted the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback